Receiving a non-compliance notice from NASDAQ is a significant regulatory issue that can lead to negative investor sentiment and potential stock price decline. The failure to file required financial reports on time is often viewed negatively by the market, as it raises concerns about a company's internal controls and financial health. This situation with Avid Bioservices could lead to decreased investor confidence and a short-term negative impact on its stock price.